Zortrax S.A.

Equities

ZRX

PLCRLNS00018

Medical Equipment, Supplies & Distribution

End-of-day quote Warsaw S.E. Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
0.142 ^PLN	-11.14%		-30.22%	-54.05%

02-14	Zortrax S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
2023	Zortrax S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Zortrax S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 14, 2024 at 08:29 pm

Zortrax S.A. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was PLN 3.69 million compared to PLN 7.53 million a year ago. Net loss was PLN 3.4 million compared to PLN 2.95 million a year ago.

Latest news about Zortrax S.A.

Zortrax S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-14	CI
Zortrax S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Zortrax S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Zortrax S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	14/02/23	CI
Zortrax S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Rusatcom Additive Technlogies LLC cancelled the acqusition of an unknown stake in Zortrax SA from Marcin Olchanowski, Rafal Tomasiak and Mariusz Babula.	28/02/22	CI
Rusatcom Additive Technlogies LLC entered into a term sheet to acquire an unknown stake in Zortrax SA from Marcin Olchanowski, Rafal Tomasiak and Mariusz Babula.	18/07/21	CI
Zortrax SA completed the acquisition of Corelens S.A. in a reverse merger transaction.	13/06/21	CI
Corelens S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/05/21	CI
Corelens S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	12/02/21	CI
Zortrax SA signed a letter of intent to acquire Corelens S.A. in a reverse merger transaction for approximately PLN 310 million.	07/09/20	CI
Zortrax Mulls Listing In 2016	19/11/15	CI
Zortrax Seeks IPO	09/02/15	CI
Zortrax Mulls IPO	11/03/14	CI

Chart Zortrax S.A.

Duration

Period

More charts

Company Profile

Zortrax SA, formerly Corelens SA, is a Poland-based company providing specialized solutions for the ophthalmic industry. The Company's business clients are public and private medical centers in Poland and the main product are intraocular lenses, which are used by doctors in cataract surgery. Other Company's products include surgical sets and disposable tools, viscoelastics and diagnostic equipment, also used by ophthalmologists during cataract surgery.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ZORTRAX S.A.	-54.05%	4.18M
ABBOTT LABORATORIES	-4.98%	182B
MEDTRONIC PLC	+2.84%	112B
BECTON, DICKINSON AND COMPANY	-2.68%	68.58B
DEXCOM, INC.	+4.53%	51.58B
CENCORA, INC.	+8.00%	44.24B
HOYA CORPORATION	+9.45%	43.65B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.30%	32.46B
WEST PHARMACEUTICAL SERVICES, INC.	-0.17%	25.61B
TERUMO CORPORATION	+20.94%	25.99B

Other Medical Equipment, Supplies & Distribution